Metraipolis › archive › dc_a30bbffcc802

Clinical characteristics and outcomes of diabetes-related ketoacidosis (DKA) in sodium-glucose co-transporter-2 inhibitor (SGLT2i) users with type 2 diabetes — Europe PMC PMID:40919651

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40919651
DOI: 10.1111/dom.70098
License (as archived): solo-consultazione
Archived: 2026-11-10T02:16:42.756Z
SHA-256 of the archived text: f15fb5e92bdafbc5ce071b0503e4abd13b8cc68cc8434c3ff662ee60fdda236c
Stable URL of this page: https://metraipolis.com/documento/dc_a30bbffcc802

How to cite

Clinical characteristics and outcomes of diabetes-related ketoacidosis (DKA) in sodium-glucose co-transporter-2 inhibitor (SGLT2i) users with type 2 diabetes — Europe PMC PMID:40919651 — Europe PMC (en), https://europepmc.org/article/MED/40919651 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a30bbffcc802 (Metraipolis archive dc_a30bbffcc802, sha256 f15fb5e92bdafbc5ce071b0503e4abd13b8cc68cc8434c3ff662ee60fdda236c)

BibTeX

@misc{dca30bbffcc802,
  title = {Clinical characteristics and outcomes of diabetes-related ketoacidosis (DKA) in sodium-glucose co-transporter-2 inhibitor (SGLT2i) users with type 2 diabetes — Europe PMC PMID:40919651},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40919651},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a30bbffcc802; sha256 f15fb5e92bdafbc5ce071b0503e4abd13b8cc68cc8434c3ff662ee60fdda236c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40919651. Agents can read the archived copy with the MCP tool read_document.